Parkinson’s disease (PD), the second-most common neurodegenerative disease, is characterized by motor and nonmotor symptoms. PD is often misdiagnosed; inappropriate treatment due to misdiagnosis has ...
January 17, 2011 — GE Healthcare has announced Food and Drug Administration (FDA) approval of ioflupane iodine-123 injection (DaTscan), a contrast agent for use with single-photon emission computed ...
DENVER, Sept. 10, 2019 /PRNewswire/ -- CereHealth Corporation through its subsidiary CereScan ®, a national network of functional brain imaging and analytics centers, announced today that it has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results